Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...

Dr. Sarah M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.

As a cancer survivor, I overcame alcohol addiction and urge others to seek support, safe detox and sobriety to improve their ...

Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE.

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...

Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied ...

New advancements in cancer treatment are reducing the need for radical surgeries, offering organ-sparing therapies and ...

Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a ...